Speech Therapy Online Approach for Children With Congenital Heart Desease in Pre and Post Surgical Period

March 16, 2026 updated by: Fernanda Lucchese, Instituto de Cardiologia do Rio Grande do Sul

The goal of this clinical trial is to test the results of a protocoled speech therapy online intervention in children with congenital heart disease aged between 0 and 12 months old, who feeds tube only.

The main questions it aims to answer are:

  • Does this online protocoled intervention helps to improve milk volume consumed by the babies though oral intake?
  • Does the ability to swallow improves by this online speech therapy approach?

Participants will be evaluated on a video call by a blinded speech therapist and will receive 10 days online intervention by the speech therapist researcher who has 10 years expertise on this population. At the end of the 10 days intervention, they will be evaluated once more by the blinded speech therapist.

Researchers will compare intervention and no intervention groups to see if there is any improvement on the oral intake volume of milk taken orally by the baby and if there is improvement on the ability of swallowing.

Study Overview

Detailed Description

The main questions it aims to answer are:

  • Does this online protocoled intervention helps to improve milk volume consumed by the babies though oral intake?
  • Does the ability to swallow improves by this online speech therapy approach?

Participants will be evaluated and will receive online intervention by the speech therapist researcher. At the end of the 10 days intervention, they will be evaluated once more.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90035-190
        • Irmandade Santa Casa de Misericordia de Porto Alegre
      • Porto Alegre, Rio Grande do Sul, Brazil, 90620-001.
        • Instituto de Cardiologia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children with congenital heart desease
  • Féd by tube only
  • Aged 0 to 12 months

Exclusion Criteria:

  • Children with vocal folds palsy
  • Children with cerebral comitment
  • Children who feds oraly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Intervention group

Intervention group After the patient's consent, a standardized complementary questionnaire will be applied, with sociodemographic and clinical information. A questionnaire assessing the life quality of the carer is also applied.

After that, the first evaluation is caried out by the blinded speech therapist. The babies are classified by level 1, level 2 or level 3, depending on the ability to manage milk orally. So they are allocated on the randomization table.

Participants will get orientations on oral stimulation. Adition informations on aversive behavior and dysphagia is also provided.
No Intervention: No intervention: Control group
Evaluation is done after enrollment and again, after 10 days. So than, the infants receive the 10 days intervention, for ethical issues.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the feasibility of a telehealth parent-mediated SLT intervention program designed to promote feeding abilities in infants with congenital heart disease (CHD) who rely on alternative feeding routes.
Time Frame: Before and after 10 days of speech therapy synchronous online intervention
Oral intake of milk volume ingestion.
Before and after 10 days of speech therapy synchronous online intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oralmotor hability
Time Frame: Before and after 10 days of speech therapy synchronous online intervention
Functional Oral Intake Scale (FOIS) was used to classify the oralmotor ability for feeding by using the protocol designed for this study
Before and after 10 days of speech therapy synchronous online intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feeding Ability Stage and Level due to the proposed protocol
Time Frame: Before and After 10-day intervention
Feeding development stage and ability level
Before and After 10-day intervention
Dysphagia Evaluation PAD-PED
Time Frame: Before and after 10 days of speech therapy synchronous online intervention
Dysphagia Evaluation (PAD-PED): Instrument to levels of Dysphasia in infants, Validated for the Brazilian Population
Before and after 10 days of speech therapy synchronous online intervention
Feeding Ability Scale
Time Frame: Before and After 10-day telehealth SLT synchronous intervention.
Feeding Readiness Scale
Before and After 10-day telehealth SLT synchronous intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

May 30, 2024

Study Completion (Actual)

May 30, 2024

Study Registration Dates

First Submitted

July 13, 2024

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 19, 2026

Study Record Updates

Last Update Posted (Actual)

March 19, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Heart Disease

Clinical Trials on Oral motor intervention

Subscribe